New Jersey § 24:6i-17
Full text of New Jersey New Jersey Statutes § 24:6i-17, with citation guidance and answers to common questions.
§ 24:6i-17.
a. (1) Each batch of medical cannabis cultivated by a medical cannabis cultivator or a clinical
registrant and each batch of a medical cannabis product manufactured by a medical cannabis manufacturer or a clinical registrant shall be tested in accordance
with the requirements of section 26 of P.L.2019, c. 153 ( C.24:6I-19 ) by a laboratory licensed pursuant to section 25 of P.L.2019, c. 153 ( C.24:6I-18 ) or cannabis testing facility licensed pursuant to section 18 of P.L.2021, c. 16 ( C.24:6I-35 ) . The laboratory or facility performing the testing shall produce a written report detailing the results of the
testing, a summary of which shall be included in any packaging materials for medical
cannabis and medical cannabis products dispensed to qualifying patients and their
designated and institutional caregivers. The laboratory or facility may charge a reasonable fee for any test performed pursuant to this section. (2) Each sample of usable cannabis, cannabis products, cannabis extracts, or other
cannabis resins from a cannabis cultivator or cannabis manufacturer may be tested
in accordance with the provisions of section 18 of P.L.2021, c. 16 ( C.24:6I-35 ) by a laboratory licensed pursuant to section 25 of P.L.2019, c. 153 ( C.24:6I-18 ). b. The requirements of paragraph (1) of subsection a. of this section shall take effect at such time as the commission certifies
that a sufficient number of laboratories have been licensed pursuant to section 25
of P.L.2019, c. 153 ( C.24:6I-18 ) , or pursuant to section 18 of P.L.2021, c. 16 ( C.24:6I-35 ), to ensure that all medical cannabis and medical cannabis products can be promptly
tested consistent with the requirements of this section without disrupting patient
access to medical cannabis. Once the requirements of that paragraph have taken effect, a laboratory licensed pursuant
to section 25 of P.L.2019, c. 153 ( C.24:6I-18 ) shall not make operational changes that reduce the prompt testing of medical cannabis
and medical cannabis products, thereby disrupting patient access to medical cannabis,
in order to test samples of usable cannabis, cannabis products, cannabis extracts,
or any other cannabis resins in accordance with section 18 of P.L.2021, c. 16 ( C.24:6I-35 ).
Frequently Asked Questions About New Jersey § 24:6i-17
What does New Jersey Statutes § 24:6i-17 cover?
Section 24:6i-17 is part of the New Jersey Statutes, the codified statutory law of New Jersey. It sets out the legal rule or procedure described in the text above. Statutes are amended regularly, so always verify against the official source.
How do I cite New Jersey § 24:6i-17?
A common citation format is "New Jersey Statutes § 24:6i-17" (New Jersey). Legal writing may require the code abbreviation, section number, and year or edition. Match the style required by your court, professor, or publisher.
Is this the official text of New Jersey law?
No. This page is for research and education and may not include the most recent amendments. For official current law, check the New Jersey official source linked on this page or consult a licensed New Jersey attorney.
How does New Jersey § 24:6i-17 apply to my situation?
Statutes are interpreted in context, and application depends on your specific facts. Only a licensed attorney in New Jersey can advise on how this section applies to you. Contact your state or local bar association for a referral.
Sources & Verification
Not legal advice. Verify against the official source and consult a licensed attorney in New Jersey.